Archive

Significant worldwide disparities in availability and timeliness of new cancer drugs

Written by | 14 Oct 2024

Despite considerable progress in the discovery and development of new cancer drugs, there are significant disparities in both the availability and timeliness of these medicines worldwide, with poorer […]

Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers

Written by | 4 Oct 2024

The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric […]

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

Written by | 21 Sep 2024

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that […]

Study finds regular aspirin use associated with greatest reduction in colorectal cancer among those most at risk

Written by | 4 Aug 2024

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by researchers at Mass […]

New test detects more cases of cervical cancer

Written by | 9 Jul 2024

Researchers at Karolinska Institutet in Sweden, in collaboration with the University of Innsbruck in Austria, have developed a simpler and more effective screening method for cervical cancer than […]

Integration of pharmacies with physician practices has little impact on cancer drug expenditures

Written by | 26 May 2024

Integration of pharmacies with physician practices, where on-site pharmacies open at physician practice locations, is a growing trend in cancer treatment. However, little is known about how this […]

Regular screening mammograms significantly reduce breast cancer deaths

Written by | 3 Dec 2023

Breast cancer mortality is significantly reduced when women regularly attend screening mammograms, according to research being presented today at the annual meeting of the Radiological Society of North America (RSNA). […]

Environment and wallet benefit from redispensing cancer pills

Written by | 26 Nov 2023

Redispensing cancer drugs reduces both environmental impact and medical costs, according to research from Radboudumc pharmacy published in JAMA Oncology. The annual savings could amount to tens of millions. […]

How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?

Written by | 13 Sep 2023

Clinicians treating cancer-related pain must consider whether and how to prescribe opioids to patients who use nonmedical stimulants such as cocaine and methamphetamines; however, no guidelines exist related […]

Breast cancer overdiagnosis common among older women

Written by | 8 Aug 2023

A study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater incidence of cancer that likely would not […]

Could pharmacist-prescribing reduce chemotherapy errors?

Written by | 24 May 2023

Shannon Nally is a pharmacist with a strong background in aseptic pharmacy work and oncology. Whilst studying for a master’s degree at University College Cork (UCC) she undertook […]

How investment could help reduce chemotherapy prescribing errors

Written by | 23 May 2023

Chemotherapy prescribing is an “error-prone process” according to Shannon Nally, the author of a study conducted at University Hospital, Limerick. The findings suggest that prescribing of chemotherapy by […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.